Background The authors recently performed plastic surgeries for a small number of patients
with hemophilia, HIV infection, and morphologic evidence of lipodystrophy. Because the …

Objective: Lipodystrophy in HIV-1–infected antiretroviral-treated patients is often associated
with opposite alterations in adipose tissue depots as follows: lipoatrophy of subcutaneous …

Objective To achieve a better understand of the pathophysiology of HIV-related lipoatrophy,
we compared the mRNA expression of adipocytokines in fat samples from patients and …

Objective: To determine HIV and antiretroviral drug distribution in plasma and fat tissue of
HIV-infected patients with lipodystrophy. Methods: Twenty-three consecutive HIV-infected …

Lipodystrophy is a common alteration in HIV 1-infected patients under anti-retroviral
treatment. This syndrome is usually associated with peripheral lipoatrophy, central adiposity …

Background The aetiopathogenic bases of HIV-1-/highly active antiretroviral treatment
(HAART)-associated lipodystrophy (HALS) are poorly known, but this syndrome indicates …

Background Lipodystrophy in HIV type-1 (HIV-1)-infected patients is the consequence of
effects originating from antiretroviral treatment and HIV-1 infection. We have studied adipose …

Objective To determine if fat distribution is altered in HIV‐infected men without clinical
evidence of lipodystrophy. Methods In a cross‐sectional design, 14 protease inhibitor (PI) …

Background: Inhibitors of HIV-1 protease produce a rapid decrease in plasma HIV-1 RNA,
with concomitant immune reconstitution. However, severe metabolic side effects together …

Objective: To determine the expressions of multiple genes in the subcutaneous adipose
tissue of HIV-positive, highly active antiretroviral therapy (HAART)-treated patients with and …